Physician profile
Ryan E Chizner
NPI 1548529662
$7,273.19
in general payments reported to CMS, 2019-2025
38 companies · $1,916 in 2025
The $1,916 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $950 · 2020: $104 · 2021: $213 · 2022: $562 · 2023: $723 · 2024: $2,804 · 2025: $1,916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,045 · Travel and Lodging: $370 · Education: $28.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,045.46 |
| Travel and Lodging | $369.87 |
| Education | $28.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,093.34 | 2019-2025 | Watchman Access System, Watchman Flx, Opticross |
| E.R. Squibb & Sons, L.L.C. | $702.98 | 2022-2025 | Camzyos, Eliquis |
| Pfizer INC. | $554.64 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $540.95 | 2022-2025 | |
| Abbott Laboratories | $475.48 | 2019-2024 | Amplatzer Amulet |
| Astrazeneca Pharmaceuticals LP | $437.50 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Merck Sharp & Dohme LLC | $378.95 | 2021-2025 | Verquvo, Winrevair |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $361.35 | 2019-2025 | Lifevest |
| Abiomed | $361.21 | 2022-2025 | Impella |
| Amgen INC. | $353.33 | 2019-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $233.62 | 2022-2025 | |
| Medtronic, INC. | $191.44 | 2022-2025 | Venaseal, Reveal Linq |
| Novo Nordisk INC | $166.73 | 2025 | Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $160.64 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $146.66 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Chizner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.